Catalyst Pharmaceuticals, Inc.
CPRX
$21.33
$0.210.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 203.07% | 129.50% | 130.18% | -41.02% | -34.49% |
| Total Depreciation and Amortization | 5.86% | 14.88% | 53.82% | 123.87% | 357.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.69% | -90.56% | -86.56% | 617.00% | 428.07% |
| Change in Net Operating Assets | 260.10% | 182.83% | 199.59% | 120.24% | -519.65% |
| Cash from Operations | 63.91% | 67.00% | 75.41% | 58.48% | 36.62% |
| Capital Expenditure | 99.02% | 99.72% | 77.49% | 78.90% | 78.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 97.60% | -1,062.48% | -593.70% |
| Cash from Investing | 99.73% | 99.81% | 84.80% | 19.17% | 14.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.35% | 5,434.20% | 2,715.55% | 1,503.37% | 1,364.01% |
| Repurchase of Common Stock | -55.99% | 31.98% | 11.10% | 11.10% | 86.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.21% | -4.07% | -4.00% | -519.48% | -861.79% |
| Cash from Financing | -97.94% | 1,395.62% | 1,807.61% | 2,029.20% | 3,731.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.65% | 336.33% | 337.88% | 712.94% | 638.30% |